John C. Reneau

Hematology
2121 Kenny Rd
Columbus, OH 43210

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Letermovir for Cytomegalovirus Prophylaxis in Patients With T-PLL Treated With Alemtuzumab.

Letermovir for Cytomegalovirus Prophylaxis in Patients With T-PLL Treated With Alemtuzumab.

Journal: Clinical lymphoma, myeloma & leukemia
Published: June 23, 2026

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

Journal: Blood
Published: April 30, 2026

Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate.

Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: February 04, 2026

A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation.

A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation.

Journal: European journal of haematology
Published: August 22, 2025

Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma.

Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma.

Journal: British journal of haematology
Published: March 28, 2025

Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.

Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.

Journal: Journal of hematology & oncology
Published: December 24, 2024

Differences in Observed Outcomes and Toxicities for Adolescent and Young Adult Patients With Aggressive Mature B-Cell Lymphomas Treated at an Adult Versus Pediatric Cancer Center.

Differences in Observed Outcomes and Toxicities for Adolescent and Young Adult Patients With Aggressive Mature B-Cell Lymphomas Treated at an Adult Versus Pediatric Cancer Center.

Journal: Pediatric blood & cancer
Published: October 14, 2024

Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity.

Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity.

Journal: npj drug discovery
Published: June 14, 2024

Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.

Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.

Journal: Leukemia & lymphoma
Published: December 14, 2023

Presenting features of indolent primary cutaneous B-cell lymphomas: Distinguishing clinical and histopathologic features.

Presenting features of indolent primary cutaneous B-cell lymphomas: Distinguishing clinical and histopathologic features.

Journal: Clinics in dermatology
Published: December 10, 2023

Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.

Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.

Journal: Blood advances
Published: October 30, 2023

Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.

Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.

Journal: Journal of hematology & oncology
Published: October 19, 2023
Showing 1-12 of 41

Last Updated: 09/26/2026